Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, believes the central problem in cancer drug development is not discovery, but a broke...

The year is off to a strong start for Mark Foundation investigators! In the first quarter, their Foundation-funded research has led to dozens of peer-reviewed papers spanning the full spectrum of…

Sid Sijbrandij's extraordinary care journey

Abstract. Purpose: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide, and early detection significantly improves treatment outcomes, but existing blood-based tests...

ASCO and Conquer Cancer will recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders who have reshaped cancer care around the world with the Society’s highest

Our recent study in Nature Communications highlights the success of a custom generative AI framework in detecting non-small cell lung cancer and its subtypes from serum-derived orphan non-coding RNAs.

Nature Communications - A generative AI model, Orion, learns a robust and generalizable pattern of non-small cell lung cancer from cancer-specific circulating non-coding RNAs. Orion enhances the...

Catching cancer at its earliest stages saves lives. But in a body made up of trillions of cells, how do you spot a small group of rogue cancer cells? Biomedical researcher Hani Goodarzi discusses his ...